Merck's cholesterol pill gets U.S. FDA approval
AI Summary
Merck has received U.S. FDA approval for its cholesterol pill Lipfendra, marking the first of its kind to be authorized by the health regulator. This approval paves the way for broader availability of the medication.
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, Lipfendra, the first of its kind to receive the health regulator's nod.